SCREENING FOR POTENTIAL SERUM PROTEIN BIOMARKERS IN HEPATOCELLULAR CARCINOMA BY MALDI-TOF/TOF MS AND VALIDATION OF CLUSTERIN IN CELLS AND TISSUES

被引：0
|
作者：
Li, Yin [1 ]
Luo, Rong [2 ]
Li, Cuiping [1 ]
Zang, Ning [2 ]
Yang, Xiaoli [2 ]
Li, Gang [2 ]
Zhang, Qinle [2 ]
Liao, Ming [2 ]
He, Xiao [1 ]
Li, Hongtao [2 ]
He, Min [1 ,2 ]
机构：
[1] Guangxi Med Univ, Sch Publ Hlth, Nanning 530021, Peoples R China
[2] Guangxi Med Univ, Minist Educ, Key Lab High Incidence Tumor Prevent & Treatment, Nanning 530021, Peoples R China
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2015年 / 63卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
105
引用
收藏
页码：S54 / S55
页数：2
相关论文
共 50 条
  • [41] Shotgun nanoLC-MS/MS proteogenomics to document MALDI-TOF biomarkers for screening new members of the Ruegeria genus
    Christie-Oleza, Joseph Alexander
    Maria Pina-Villalonga, Juana
    Guerin, Philippe
    Miotello, Guylaine
    Bosch, Rafael
    Nogales, Balbina
    Armengaud, Jean
    ENVIRONMENTAL MICROBIOLOGY, 2013, 15 (01) : 133 - 147
  • [42] Screening for potential allergens with proteomic MALDI-TOF read-out
    Dietz, L.
    Pankert, P.
    Ohnesorge, S.
    Eikelmeier, S.
    Schnoelzer, M.
    Thierse, H.
    EXPERIMENTAL DERMATOLOGY, 2009, 18 (03) : 326 - 326
  • [43] Clinical Validation of a 106-SNV MALDI-ToF MS Pharmacogenomic Panel
    Williams, Grace R.
    Cook, Leanne
    Lewis, Lionel D.
    Tsongalis, Gregory J.
    Nerenz, Robert D.
    JOURNAL OF APPLIED LABORATORY MEDICINE, 2020, 5 (03): : 454 - 466
  • [44] MALDI-TOF/MS Analysis of Extracellular Vesicles Released by Cancer Cells
    Zambonin, Carlo
    APPLIED SCIENCES-BASEL, 2022, 12 (12):
  • [45] Development and validation of an extended database for yeast identification by MALDI-TOF MS in Argentina
    Giselle Taverna, Constanza
    Mazza, Mariana
    Soledad Bueno, Nadia
    Alvarez, Christian
    Amigot, Susana
    Andreani, Mariana
    Azula, Natalia
    Barrios, Ruben
    Fernandez, Norma
    Fox, Barbara
    Guelfand, Liliana
    Maldonado, Ivana
    Alejandro Murisengo, Omar
    Relloso, Silvia
    Vivot, Matias
    Davel, Graciela
    MEDICAL MYCOLOGY, 2019, 57 (02) : 215 - 225
  • [46] MALDI-TOF MS MUTATION ANALYSIS FOR NSCLC CIRCULATING TUMOR CELLS
    Erickson, Heidi S.
    Hanson, Nana E.
    Stemke-Hale, Katherine
    Galindo, Hector G.
    Giri, Uma
    Mcdowell, Christina
    Girard, Luc
    Lee, J. J.
    Herbst, Roy
    Minna, John D.
    Hai Tran
    Mills, Gordon B.
    Kim, Edward
    Heymach, John V.
    Wistuba, Ignacio
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S669 - S669
  • [47] MALDI-TOF MS as a Label-Free Approach to Rapid Inhibitor Screening
    Greis, Kenneth D.
    Zhou, Songtao
    Burt, Thomas M.
    Carr, Andrew N.
    Dolan, Elizabeth
    Easwaran, Vijayasurian
    Evdokimov, Artem
    Kawamoto, Richard
    Roesgen, Jeff
    Davis, Gregory F.
    Journal of the American Society for Mass Spectrometry, 2006, 17 (06): : 815 - 822
  • [48] Immunoaffinity sample purification and MALDI-TOF MS analysis of α-solanine and α-chaconine in serum
    Driedger, DR
    Sporns, P
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2001, 49 (02) : 543 - 548
  • [49] Evaluation of serum carbohydrate-deficient transferrin by HPLC and MALDI-TOF MS
    Sogawa, Kazuyuki
    Iida, Fumie
    Kawshima, Yusuke
    Yamada, Mako
    Satoh, Mamoru
    Sanda, Akihiro
    Takizawa, Hirotaka
    Maruyama, Katsuya
    Wada, Yoshinao
    Nomura, Fumio
    CLINICA CHIMICA ACTA, 2015, 448 : 8 - 12
  • [50] Detection of colorectal cancer using MALDI-TOF serum protein profiling
    de Novo, ME
    van der Werff, MPJ
    van de Velde, CJH
    Deelder, AM
    Tollenaar, RAEM
    ANNALS OF ONCOLOGY, 2006, 17
12345